Waverton Investment Management LTD Blueprint Medicines Corp Transaction History

Waverton Investment Management LTD

  • $5.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 06, 2018
SELL
$73.28 - $102.95 $1.08 Million - $1.52 Million
-14,760 Closed
0 $0
Q4 2017

Jan 10, 2018
BUY
$62.91 - $88.32 $142,176 - $199,603
2,260 Added 18.08%
14,760 $1.11 Million
Q3 2017

Oct 12, 2017
BUY
$42.37 - $69.67 $529,625 - $870,875
12,500
12,500 $871,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Waverton Investment Management LTD Portfolio

Follow Waverton Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email